BioSpace News Archive

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced the appointment of Jeffery D. Mowery as Site Head/General Manager of the Copenhagen, Denmark facility.

Lands’ End Partners with BCRF for Breast Cancer Awareness Month

Transaction Adds Hospice Services through 21 Locations Across Six States, Producing Annualized Revenue of Approximately $55 Million

Reduces Telehealth Program Costs and Liability for Partner Hospitals

Results Support Ongoing Phase 2 ELEVATE 1 Study in Pulmonary Arterial Hypertension

Protagonist Therapeutics, Inc. announced that abstracts providing data from the PN-943 and PTG-200 clinical programs have been accepted for poster presentations at upcoming scientific conferences.

CTI BioPharma Corp. announced that it has initiated patient enrollment in the PACIFICA pivotal Phase 3 trial of its investigational myelofibrosis treatment candidate, pacritinib.

T cell receptor (TCR) T cell therapy targeting HA-1 expressing tumors designed to manage post-hematopoietic stem cell transplant leukemic relapse

CMP-001, a TLR9 Agonist, to be Evaluated in Combination with BAVENCIO®; with or without Utomilumab, a 4-1BB Agonist, and PF-04518600, an OX40 Agonist

Tmunity Therapeutics, Inc. announced it has entered into an exclusive license and research collaboration agreement with Children’s Hospital of Philadelphia to advance a glypican 2 chimeric antigen receptor T-cell therapy for the treatment of neuroblastoma, a rare cancer that affects the developing nervous system.